Adaptate is a biotherapeutics company that develops antibodies to modulate gamma delta T cells in situ.
Adaptate is a biotherapeutics company that develops antibodies to modulate gamma delta T cells in situ. The company was founded in 2019 by Adrian Hayday and is headquartered in London.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 19, 2021 | Series A | £13M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Abingworth | — | Series A |
Takeda Ventures | — | Series A |